0/ #BigNews. Our #mRNA @mips vaccine will be fast-tracked to Phase-I clinical trial. The trial is led by our amazing collaborators @TheDohertyInst that includes two candidates mRNA and protein. Why still working on #COVID19 mRNA vaccine in Aus, people ask? Here're #4reasons:
#Reason 1: #Protection at a rapid speed: Our vaccines use a 2nd-generation technology and antigen design that is both effective and rapid. This method allowed us to produce a safe mRNA vax within 3 weeks. ESSENTIAL for rapid response if the virus continues to mutate-saving lives!
#Reason 2: #manufacturing: We have extensive Aus-only experience in #mRNA. More to come but we are in talks with many entities here in Aus and we will try all avenues to convince the relevant groups to help us build the capacity here in Aus. This will be gradual but ESSENTIAL.
#Sidenote: We saw how important onshore #Manufacturing capacity on not selecting #mRNA vaccines. This will ensure that Australia has all technological advances in order to produce #mRNA vaccines onshore for future epidemics or other diseases' clinical trials that use mRNA. winwin
#Reason 3: Distribution/Temperature: This one is important to me. We already have promising results for more tolerable temperature storage (-20/4 C or a combination). More to come in the next few months. We know improvement on this front will put mRNA technology at the forefront.
#Reason 4: #Innovation/economical impact: our mRNA innovations in #nanotechnology of the carriers and the #mRNA design, manufacturing and storing will galvanise bioinnovation in Australia with economic impact directly benefiting taxpayers and researchers designing other vaccines.
Finally, I would like to thank so many people who got us here. My amazing team, Colin's leadership, Doherty collaborators who are leading the trials, the MRFF fund and all my industry, biotech, and academic research collaborators who their enthusiasm for mRNA kept us moving!
Announcement here for more info : monash.edu/pharm/about/ne…
Here is an extended conversation about mRNA manufacturing and its importance in Australia. smh.com.au/business/small…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
